127 related articles for article (PubMed ID: 35142223)
1. Cisplatin-Chelated Iminodiacetic Acid-Conjugated Hyaluronic Acid Nanogels for the Treatment of Malignant Pleural Mesothelioma in Mice.
Amano Y; Sakura KL; Ohta S; Ito T
Mol Pharm; 2022 Mar; 19(3):853-861. PubMed ID: 35142223
[TBL] [Abstract][Full Text] [Related]
2. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.
Onen HI; Yilmaz A; Alp E; Celik A; Demiroz SM; Konac E; Kurul IC; Menevse ES
Hum Exp Toxicol; 2015 Feb; 34(2):117-26. PubMed ID: 25028262
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal Delivery of Cisplatin via a Hyaluronan-Based Nanogel/in Situ Cross-Linkable Hydrogel Hybrid System for Peritoneal Dissemination of Gastric Cancer.
Ohta S; Hiramoto S; Amano Y; Emoto S; Yamaguchi H; Ishigami H; Kitayama J; Ito T
Mol Pharm; 2017 Sep; 14(9):3105-3113. PubMed ID: 28806513
[TBL] [Abstract][Full Text] [Related]
4. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.
Borchert S; Suckrau PM; Walter RFH; Wessolly M; Mairinger E; Steinborn J; Hegedus B; Hager T; Herold T; Eberhardt WEE; Wohlschlaeger J; Aigner C; Bankfalvi A; Schmid KW; Mairinger FD
Sci Rep; 2020 Oct; 10(1):18677. PubMed ID: 33122816
[TBL] [Abstract][Full Text] [Related]
5. Production of Cisplatin-Incorporating Hyaluronan Nanogels via Chelating Ligand-Metal Coordination.
Ohta S; Hiramoto S; Amano Y; Sato M; Suzuki Y; Shinohara M; Emoto S; Yamaguchi H; Ishigami H; Sakai Y; Kitayama J; Ito T
Bioconjug Chem; 2016 Mar; 27(3):504-8. PubMed ID: 26781684
[TBL] [Abstract][Full Text] [Related]
6. Pemetrexed-conjugated hyaluronan for the treatment of malignant pleural mesothelioma.
Amano Y; Ohta S; Sakura KL; Ito T
Eur J Pharm Sci; 2019 Oct; 138():105008. PubMed ID: 31302213
[TBL] [Abstract][Full Text] [Related]
7. Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed.
Ando H; Kobayashi S; Abu Lila AS; Eldin NE; Kato C; Shimizu T; Ukawa M; Kawazoe K; Ishida T
J Control Release; 2015 Dec; 220(Pt A):29-36. PubMed ID: 26476173
[TBL] [Abstract][Full Text] [Related]
8. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
9. Anticancer agent α-sulfoquinovosyl-acylpropanediol enhances the radiosensitivity of human malignant mesothelioma in nude mouse models.
Inamasu E; Tsuchiya T; Yamauchi M; Nishi K; Matsuda K; Sugawara F; Sakaguchi K; Mori R; Matsumoto K; Miyazaki T; Hatachi G; Doi R; Watanabe H; Tomoshige K; Matsuda N; Higami Y; Shimokawa I; Nakashima M; Nagayasu T
J Radiat Res; 2022 Jan; 63(1):19-29. PubMed ID: 34738103
[TBL] [Abstract][Full Text] [Related]
10. Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model.
Sonvico F; Barbieri S; Colombo P; Barocelli E; Mucchino C; Cantoni AM; Petronini PG; Rusca M; Carbognani P; Ampollini L
Eur J Pharm Sci; 2018 Oct; 123():89-97. PubMed ID: 30030099
[TBL] [Abstract][Full Text] [Related]
11. Effects of cisplatin and panobinostat on human mesothelial (Met-5A) and malignant pleural mesothelioma (MSTO-211H) cells.
Gultekin KE; Yurdakonar MK; Yaman E; Yuce US; Yilmaz A; Alp E; Celik A; Demiroz SM; Onen HI
Genet Mol Res; 2013 Nov; 12(4):5405-13. PubMed ID: 24301913
[TBL] [Abstract][Full Text] [Related]
12. Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma.
Otsuki T; Nakashima T; Hamada H; Takayama Y; Akita S; Masuda T; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Miyake M; Kohno N; Okada M; Hattori N
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29519924
[TBL] [Abstract][Full Text] [Related]
13. Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.
Spugnini EP; Cardillo I; Verdina A; Crispi S; Saviozzi S; Calogero R; Nebbioso A; Altucci L; Cortese G; Galati R; Chien J; Shridhar V; Vincenzi B; Citro G; Cognetti F; Sacchi A; Baldi A
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6133-43. PubMed ID: 17062690
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma.
Fujimoto N; Gemba K; Asano M; Fuchimoto Y; Wada S; Ono K; Ozaki S; Kishimoto T
Respir Investig; 2013 Jun; 51(2):92-7. PubMed ID: 23790737
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Enhancement of Cellular Uptake With CD44-Expressing Malignant Pleural Mesothelioma by Combining Cationic Liposome and Hyaluronic Acid-Lipid Conjugate.
Sakurai Y; Kato A; Hida Y; Hamada J; Maishi N; Hida K; Harashima H
J Pharm Sci; 2019 Oct; 108(10):3218-3224. PubMed ID: 31229434
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma.
Li Q; Wang W; Machino Y; Yamada T; Kita K; Oshima M; Sekido Y; Tsuchiya M; Suzuki Y; Nan-Ya K; Iida S; Nakamura K; Iwakiri S; Itoi K; Yano S
Cancer Sci; 2015 Jan; 106(1):102-7. PubMed ID: 25421609
[TBL] [Abstract][Full Text] [Related]
17. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.
Hoda MA; Pirker C; Dong Y; Schelch K; Heffeter P; Kryeziu K; van Schoonhoven S; Klikovits T; Laszlo V; Rozsas A; Ozsvar J; Klepetko W; Döme B; Grusch M; Hegedüs B; Berger W
Mol Cancer Ther; 2016 Oct; 15(10):2357-2369. PubMed ID: 27512118
[TBL] [Abstract][Full Text] [Related]
18. Folate conjugated hyaluronic acid coated alginate nanogels encapsulated oxaliplatin enhance antitumor and apoptosis efficacy on colorectal cancer cells (HT29 cell line).
Shad PM; Karizi SZ; Javan RS; Mirzaie A; Noorbazargan H; Akbarzadeh I; Rezaie H
Toxicol In Vitro; 2020 Jun; 65():104756. PubMed ID: 31884114
[TBL] [Abstract][Full Text] [Related]
19. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M
Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
[TBL] [Abstract][Full Text] [Related]
20. Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.
Riquelme E; Suraokar MB; Rodriguez J; Mino B; Lin HY; Rice DC; Tsao A; Wistuba II
J Thorac Oncol; 2014 Jul; 9(7):998-1007. PubMed ID: 24926545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]